Skip to main content
HR 1362 116th Congress House

Medical Innovation Never Stops Act of 2019

Official title: To amend the Federal Food, Drug, and Cosmetic Act to allow, during a lapse in appropriations, acceptance of certain device submissions and registrations with t… Show full official titleShow less

Official title: To amend the Federal Food, Drug, and Cosmetic Act to allow, during a lapse in appropriations, acceptance of certain device submissions and registrations with the corresponding fees made available for obligation and expenditure for the process for the review of device applications, and for other purposes.

Introduced: February 26, 2019 Introduced by: Emmer, Tom Republican · Minnesota See on congress.gov
Health AppropriationsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structure
More subjectsShow fewer subjects
Licensing and registrationsUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2019
Referred to the Subcommittee on Health.
Feb 26, 2019
Referred to the House Committee on Energy and Commerce.
Feb 26, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 27, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Medical Innovation Never Stops Act of 2019

This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1362: Medical Innovation Never Stops Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-1362/
MLA
"H.R. 1362: Medical Innovation Never Stops Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-1362/.
Bluebook (legal)
H.R. 1362, 116th Cong. (2026), https://openamerica.io/bill/116-HR-1362/.
Markdown link
[H.R. 1362: Medical Innovation Never Stops Act of 2019](https://openamerica.io/bill/116-HR-1362/)
Report a problem